Clinical evaluation of an application aid for less-invasive surfactant administration (LISA)

Christian A. Maiwald, Patrick Neuberger, Axel R. Franz, Corinna Engel, Matthias Vochem, Christian F. Poets

Archives of Disease in Childhood Fetal & Neonatal · 2020 · 17 citations · 5 references

DOIFull text

Open access

Concepts

Abstract

Background Less-invasive surfactant administration (LISA) is increasingly used. We investigated the feasibility of a new LISA-device (Neofact®) in neonates. Design Prospective observational pilot study with open-label LISA in two tertiary neonatal intensive care units. Patients 20 infants with a gestational age of ≥26+0/7 weeks and an indication for LISA (Respiratory Severity Score (RSS)≥5 or fraction of inspired oxygen (FiO 2 ) ≥0.30). Infants with respiratory tract malformations or unavailability of an instructed neonatologist were excluded. Main outcome measures Success of LISA, defined as laryngoscopy-confirmed intratracheal catheter position or a decrease in FiO 2 by ≥0.05 or to 0.21, accompanied by an RSS decrease of ≥2; number of attempts needed for tracheal catheterisation. Results 20/57 screened infants were enrolled. Successful application occurred in 19/20 (95%). One application failed after three attempts. No device-related adverse events occurred. The median number of attempts was 2, success rate per attempt 19/31 (61%). Conclusion LISA via Neofact® appears feasible.

References

5